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31
P NMR spectra were standardised externally with 85% phosphoric acid: δ P = 0.000 ppm.
All 13 C and 31 P spectra were proton decoupled. Chemical shifts (δ) are in ppm and the multiplicity of 
Numbering of atoms
For the purpose of the assignment of signals obtained from the NMR spectra of the synthesised compounds, i. e. carbon atoms, CH and OH protons, respectively, the following numbering of the 2´-deoxynucleoside scaffold as well as the propargyl group is used:
Abbreviations
Abbreviations used for chemicals and chemical moieties: 
3´-O-TBDMS-5´-O-DMT-thymidine (2a)
. Under Ar, 1a (3.50 g, 6.43 mmol) was dissolved in dry DCM (10 mL), followed by the consecutive addition of imidazole (1.90 g, 28.20 mmol, 4.4 equiv) and TBDMS-Cl (4.20 g, 27.87 mmol, 4.0 equiv), both as a solution in a minimal amount of dry DCM. The mixture was stirred at ambient temperature until TLC indicated complete consumption of the starting material (12 hours). MeOH (2 mL) was added and the solution was poured into EtOAc (70 mL). The organic layer was extracted with 5% aqueous NaHCO 3 (2 x 50 mL) and washed with water (1 x 50 mL) and brine (1 x 50 mL). Drying of the organic layer with anhydrous MgSO 4 and evaporation to dryness gave a colourless solid (3.64 g, 5.53 mmol, 86%, m.p. 108-112 °C (10 mL), followed by the dropwise addition of CEP-Cl (0.12 mL, 0.52 mmol, 1.3 equiv). The reaction mixture was stirred for 2 hours at ambient temperature. Aqueous NaHCO 3 (5%, 40 mL) was added and the product was extracted with DCM (3 x 20 mL). The organic layer was dried with anhydrous = 3280, 3114, 2929, 2866, 2275, 1711, 1679, 1609, 1335, 1200, 1180, 1049, 1021, 1000, 972, 824 (cm -1 2929, 2831, 1679, 1605, 1511, 1458, 1376, 1245, 1176, 1090, 1029, 824 (cm -1 2851, 1683, 1621, 1605, 1635, 1503, 1458, 1384, 1274, 1172, 1102, 1029, 1000, 829 (cm -1 3284, 2950, 2925, 2851, 1635, 1604, 1578, 1507, 1459, 1443, 1295, 1248, 1174, 1103, 1029, 828 (cm -1 78, 127.71, 127.90; 129.74 (m-C, aryl), ipso-C (phenyl): 135.31, 135.43; ipso-C (aryl): 144.72, 158.11. FT-IR (neat): ṽ = 3276, 2925 , 2835 , 1638 , 1572 , 1458 , 1442 , 1298 , 1245 , 1168 , 1082 , 1029 = 3375, 2975, 2931, 2874, 2357, 2325, 1808, 1672, 1563, 1521, 1448, 1376, 1308, 1182, 1130, 1049, 945, 845 (cm -1 -10  0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200 f1 (ppm) 
Synthesis of

Oligonucleotide Synthesis and Work-up Procedure
The oligodeoxynucleotides were synthesised at a 1 µmol scale on an Expedite 8909 DNA/RNA synthesiser (ABI/PerSeptiveBiosystems) in the DMT-off mode and by using strandard ß-cyanoethyl phosphoramidite chemistry. Standard chemical procedures for deprotection and cleavage of the obtained oligonucleotides from the preloaded CPG solid support was followed, i.e. treatment with a 3:1 mixture of concentrated NH 3 in water/ethanol (3:1) at 55 °C overnight. After dr ying of the crude oligonucleotides using a SpeedVac, the samples were injected onto a Dionex DNAPac PA200 anion exchange column via HPLC to separate the full-length oligonucleotide strands from the abortion
products. An elution system consisting of increasing concentrations of NaClO 4 in Tris buffer (pH 8) was used. The following gradient for anion exchange purification was used: The desired oligodeoxynucleotides were obtained after desalting on Nap columns and were ready for hybridisation and melting experiments. The masses of the synthesised oligonucleotides were confirmed by MALDI-TOF mass spectra (positive mode), which were obtained from a Bruker BIFLEX III spectrometer using the matrix 3-hydroxypicolinic acid/(NH 4 ) 2 -citrate. Table S1 . Sequences of the in-house synthesised oligodeoxynucleotides, showing the varying positions of modification. 
MALDI-TOF
